Clavanin A vs omega-conotoxin MVIIA
Head-to-head comparison of Clavanin A (Clavanin A (tunicate-derived antimicrobial peptide)) and omega-conotoxin MVIIA (Ziconotide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Clavanin A | omega-conotoxin MVIIA |
|---|---|---|
| Category | Marine-Derived | Marine-Derived |
| Full Name | Clavanin A (tunicate-derived antimicrobial peptide) | Ziconotide |
| Molecular Weight | ~2.6 kDa | 2639 Da |
| Half-Life | NR | 4.5 h (CSF) |
| Amino Acids | 23 | 25 |
| Typical Dose | NR | 1.2 mcg/day initial, titrate as tolerated |
| Route | in vitro|topical preclinical | intrathecal |
| Purity | ≥98% | ≥98% |
| Studies Count | 83 | 78 |
| Research Status | Pre-clinical | Approved |
Clavanin A Benefits
- ✓antibacterial
- ✓anti-inflammatory
- ✓wound-healing lead
omega-conotoxin MVIIA Benefits
- ✓analgesic
- ✓ion-channel blocker
- ✓neuroactive
Clavanin A Dosing
NR|NR
omega-conotoxin MVIIA Dosing
chronic refractory pain|CaV2.2
Clavanin A Side Effects
- ⚠hemolysis at high concentrations
- ⚠immunogenicity risk
- ⚠protease sensitivity
omega-conotoxin MVIIA Side Effects
- ⚠Conus magus
Research Overview
Clavanin A
Preclinical work supports broad antibacterial activity and some host-modulating effects, especially in skin and wound models. Activity can be improved through sequence optimization and formulation strategies.
omega-conotoxin MVIIA
Foundational marine peptide drug; approved as ziconotide for intrathecal treatment of severe chronic pain when other therapies fail.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.
Related Comparisons
Common Stacking Partners
Clavanin A stacks with:
Clavanin
omega-conotoxin MVIIA stacks with:
Conus magusomega-conotoxinpain
marine-derivedantimicrobial peptidebioactive peptidebioactivecone snailpeptide drug